PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Mephenesin→

Mephenesin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
59-47-2
Molecular formula
C10H14O3
Molecular weight
182.22 g/mol
Drug class
Centrally acting skeletal muscle relaxantpropanediol derivative
Mechanism of action
The exact mechanism is not fully established. Mephenesin reduces central polysynaptic reflex activity and has been observed to block neuronal sodium and calcium currents, producing short-duration skeletal-muscle relaxation.
Indications / reported uses
  • Historically used for short-term relief of painful skeletal-muscle spasm; it is an older agent and is not a standard contemporary muscle-relaxant treatment in many jurisdictions.

Sources: https://www.ncbi.nlm.nih.gov/mesh/68008615 · https://pubchem.ncbi.nlm.nih.gov/compound/mephenesin

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Mephenesin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Mephenesin Permitted Daily Exposure (PDE) report (the Mephenesin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Mephenesin Occupational Exposure Limit (OEL) report (the Mephenesin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.